Tricuspid-valve regurgitant jet velocity as a risk factor for death in β-thalassemia | Haematologica
![PDF] Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: Lesson from Günther disease model PDF] Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: Lesson from Günther disease model](https://i1.rgstatic.net/publication/309957914_Hemolytic_anemia_repressed_hepcidin_level_without_hepatocyte_iron_overload_Lesson_from_Gunther_disease_model/links/5e1ee05692851c3cbe657577/largepreview.png)
PDF] Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: Lesson from Günther disease model
Replacing the suppressed hormone: toward a better treatment for iron overload in β-thalassemia major? | Haematologica
Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease | Haematologica
Hydroxyurea differentially modulates activator and repressors of γ-globin gene in erythroblasts of responsive and non-responsiv
![Sickle cell disease is a global prototype for integrative research and healthcare - Royal - 2021 - Advanced Genetics - Wiley Online Library Sickle cell disease is a global prototype for integrative research and healthcare - Royal - 2021 - Advanced Genetics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/97b7828a-d445-4dbe-a400-ff41c1daeb01/ggn210037-fig-0001-m.jpg)
Sickle cell disease is a global prototype for integrative research and healthcare - Royal - 2021 - Advanced Genetics - Wiley Online Library
Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease | Haematologica
![Cancers | Free Full-Text | Targeting Leukemia-Initiating Cells and Leukemic Niches: The Next Therapy Station for T-Cell Acute Lymphoblastic Leukemia? Cancers | Free Full-Text | Targeting Leukemia-Initiating Cells and Leukemic Niches: The Next Therapy Station for T-Cell Acute Lymphoblastic Leukemia?](https://www.mdpi.com/cancers/cancers-14-05655/article_deploy/html/images/cancers-14-05655-ag.png)
Cancers | Free Full-Text | Targeting Leukemia-Initiating Cells and Leukemic Niches: The Next Therapy Station for T-Cell Acute Lymphoblastic Leukemia?
Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the Europ
Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective | Haematologica
Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective | Haematologica
![Quality of life in patients with β‐thalassemia: A prospective study of transfusion‐dependent and non‐transfusion‐dependent patients in Greece, Italy, Lebanon, and Thailand - Cappellini - 2019 - American Journal of Hematology - Wiley Quality of life in patients with β‐thalassemia: A prospective study of transfusion‐dependent and non‐transfusion‐dependent patients in Greece, Italy, Lebanon, and Thailand - Cappellini - 2019 - American Journal of Hematology - Wiley](https://onlinelibrary.wiley.com/cms/asset/a3ab599c-f810-44a4-8d26-916b998a40ec/ajh.25584.fp.png)
Quality of life in patients with β‐thalassemia: A prospective study of transfusion‐dependent and non‐transfusion‐dependent patients in Greece, Italy, Lebanon, and Thailand - Cappellini - 2019 - American Journal of Hematology - Wiley
![Evaluation of two in vitro assays for tumorigenicity assessment of CRISPR-Cas9 genome-edited cells: Molecular Therapy - Methods & Clinical Development Evaluation of two in vitro assays for tumorigenicity assessment of CRISPR-Cas9 genome-edited cells: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/attachment/8fc6c8fc-4278-46f3-8889-44b9eb1ec507/fx1_lrg.jpg)